Placeholder

Master Plan: The Making of a Successful Publication Strategy

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 874. Categories: , , .

Product Description

Publication planning is an essential part of the drug-development process. The results of the long, labor-intensive years of a clinical trial are announced to the industry and medical professionals through publication in medical journals.
Preparing trial results for publication requires early planning to ensure that important scientific data are communicated to the appropriate audience in a timely manner. Finding the right balance between faster publication and a credible vehicle for information, however has become confounded in recent times because of public concerns regarding transparency and authorship disclosures and the creation of clinical-trial registries and results databases…

Sidebars:
Publication Planning: Coming of Age
Sound Bites from the Field
Chris Dickey, DrPH
, VP and General Manager, Medical Intelligence Solutions. For more information, visit medintelsolutions.com.
Dan Donovan, President, Envision Pharma Inc. For more information, visit envisionpharma.com.

Experts on this topic
Timothy D. Bacon.
President and CEO, PeerView Inc., Newtown, Pa.; PeerView provides a growing range of Web-based decision-support, program management, and competitive intelligence products that support publication strategy and other commercialization processes. For more information, visit epeerview.com.
Bhakti Kshatriya, Pharm.D. Associate Director, Global Medical Affairs, OTC R&D, Novartis Consumer Health, Parsippany, N.J.; Novartis Consumer Health creates, develops, manufactures, and markets a wide range of competitively differentiated products that restore, maintain, or improve the health and well-being of consumers. For more information, visit novartis.com.
Neil Matheson. CEO, Axis Healthcare Communications, Yardley, Pa.; Axis is a global medical communications company that provides a full spectrum of healthcare communications services through its strategic consulting, medical communications, medical education, healthcare advertising, e-business, and sales training agencies. For more information, visit axis-healthcare.com.
Robert Norris. President, Complete Healthcare Communications Inc. (CHC), Chadds Ford, Pa., and President, International Society for Medical Publication Professionals (ISMPP), Briarcliff Manor, N.Y.; CHC is a strategic medical communications agency that specializes in publication planning. For more information, visit chcinc.com. The ISMPP provides advocacy and education to those involved in publication planning on a range of issues. For more information, visit ismpp.org.
Julia Ralston. President and CEO, MedErgy HealthGroup Inc., Yardley, Pa.; MedErgy HealthGroup is a medical marketing agency that blends strategy, science, and creative to ensure promising products become commercially successful brands. For more information, visit medergygroup.com.
Philip D. Ross, Ph.D. Senior Director and Acting Head, Medical Communications Department, Merck Research Laboratories, Merck & Co. Inc., Whitehouse Station, N.J.; Merck is a global research-driven pharmaceutical products company. For more information, visit merck.com.
Dora P. Shankman. President and CEO, Shankman Marketing and Media Resources LLC, Basking Ridge, N.J.; Shankman Marketing is a communications company that provides strategic media planning, publication planning, and all promotional negotiations and purchasing for pharmaceutical companies and companies in the healthcare industry. For more information, contact smmrllc@aol.com.

FEEDBACK